Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma.

Autor: Thomas N; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada., Dreval K; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada., Gerhard DS; Office of Cancer Genomics, National Cancer Institute, National Institutes of Health, Bethesda, MD., Hilton LK; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Abramson JS; Center for Lymphoma, Massachusetts General Hospital, Harvard Medical School, Boston, MA., Ambinder RF; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD., Barta S; University of Pennsylvania Hospital, Philadelphia, PA., Bartlett NL; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO., Bethony J; Department of Microbiology, Immunology, and Tropical Medicine, George Washington University, Washington, DC., Bhatia K; Lantern Pharma, Inc, Dallas, TX., Bowen J; Biopathology Center, Nationwide Children's Hospital, Columbus, OH., Bryan AC; Biopathology Center, Nationwide Children's Hospital, Columbus, OH., Cesarman E; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, Cornell University, New York, NY., Casper C; Infectious Disease Research Institute, Seattle, WA., Chadburn A; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY., Cruz M; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada., Dittmer DP; Lineberger Comprehensive Cancer Center and Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC., Dyer MA; Clinical Research Directorate, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, MD., Farinha P; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Gastier-Foster JM; Biopathology Center, Nationwide Children's Hospital, Columbus, OH.; Departments of Pathology and Pediatrics, The Ohio State University, Columbus, OH., Gerrie AS; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Grande BM; Sage Bionetworks, Seattle, WA., Greiner T; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE., Griner NB; Office of Cancer Genomics, National Cancer Institute, National Institutes of Health, Bethesda, MD., Gross TG; Center for Global Health, National Cancer Institute, National Institutes of Health, Rockville, MD., Harris NL; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA., Irvin JD; Foundation for Burkitt Lymphoma Research, Geneva, Switzerland., Jaffe ES; Laboratory of Pathology, Clinical Center, National Cancer Institute, National Institutes of Health, Bethesda, MD., Henry D; University of Pennsylvania Hospital, Philadelphia, PA., Huppi R; Office of HIV/AIDS Malignancies, National Cancer Institute, National Institutes of Health, Bethesda, MD., Leal FE; Programa de Oncovirologia, Instituto Nacional de Cancer Jose de Alencar, Rio de Janeiro, Brazil., Lee MS; University of North Carolina at Chapel Hill, Chapel Hill, NC., Martin JP; Foundation for Burkitt Lymphoma Research, Geneva, Switzerland., Martin MR; Foundation for Burkitt Lymphoma Research, Geneva, Switzerland., Mbulaiteye SM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD., Mitsuyasu R; Center for Clinical AIDS Research and Education, University of California Los Angeles, Los Angeles, CA., Morris V; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Mullighan CG; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN., Mungall AJ; Canada's Michael Smith Genome Sciences Centre at BC Cancer, Vancouver, BC, Canada., Mungall K; Canada's Michael Smith Genome Sciences Centre at BC Cancer, Vancouver, BC, Canada., Mutyaba I; Uganda Cancer Institute, Kampala, Uganda., Nokta M; Office of HIV/AIDS Malignancies, National Cancer Institute, National Institutes of Health, Bethesda, MD., Namirembe C; Uganda Cancer Institute, Kampala, Uganda., Noy A; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY., Ogwang MD; EMBLEM Study, St. Mary's Hospital Lacor, Gulu, Uganda., Omoding A; Uganda Cancer Institute, Kampala, Uganda., Orem J; Uganda Cancer Institute, Kampala, Uganda., Ott G; Department of Clinical Pathology, Robert-Bosch-Krankenhaus and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany., Petrello H; Biopathology Center, Nationwide Children's Hospital, Columbus, OH., Pittaluga S; Laboratory of Pathology, Clinical Center, National Cancer Institute, National Institutes of Health, Bethesda, MD., Phelan JD; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Ramos JC; Department of Medicine, Division of Hematology, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL., Ratner L; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO., Reynolds SJ; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., Rubinstein PG; Section of Hematology/Oncology, John H. Stroger Jr Hospital of Cook County, Chicago, IL., Sissolak G; Tygerberg Academic Hospital and Stellenbosch University, Cape Town, South Africa., Slack G; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Soudi S; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada., Swerdlow SH; Division of Hematopathology, University of Pittsburgh School of Medicine, Pittsburgh, PA., Traverse-Glehen A; Hospices Civils de Lyon, Université Lyon 1, Service d'Anatomie Pathologique, Hopital Lyon Sud France., Wilson WH; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Wong J; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Yarchoan R; Office of HIV/AIDS Malignancies, National Cancer Institute, National Institutes of Health, Bethesda, MD., ZenKlusen JC; The Cancer Genome Atlas, Center for Cancer Genomics, National Cancer Institute, National Institutes of Health, Bethesda, MD., Marra MA; Canada's Michael Smith Genome Sciences Centre at BC Cancer, Vancouver, BC, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada., Staudt LM; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Scott DW; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Morin RD; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Canada's Michael Smith Genome Sciences Centre at BC Cancer, Vancouver, BC, Canada.

Publikováno v: Blood [Blood] 2023 Feb 23; Vol. 141 (8), pp. 904-916.

Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade-specific epigenome and transcriptome landscapes.

Autor: Gagliardi A; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada., Porter VL; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada., Zong Z; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada., Bowlby R; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada., Titmuss E; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada., Namirembe C; Uganda Cancer Institute, Kampala, Uganda., Griner NB; Office of Cancer Genomics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Petrello H; Nationwide Children's Hospital, Columbus, OH, USA., Bowen J; Nationwide Children's Hospital, Columbus, OH, USA., Chan SK; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada., Culibrk L; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada., Darragh TM; Department of Pathology, University of California at San Francisco, San Francisco, CA, USA., Stoler MH; Department of Pathology, University of Virginia, Charlottesville, VA, USA., Wright TC; Department of Pathology and Cell Biology, Columbia University, New York, NY, USA., Gesuwan P; Office of Cancer Genomics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Dyer MA; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Ma Y; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada., Mungall KL; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada., Jones SJM; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada., Nakisige C; Uganda Cancer Institute, Kampala, Uganda., Novik K; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada., Orem J; Uganda Cancer Institute, Kampala, Uganda., Origa M; Uganda Cancer Institute, Kampala, Uganda., Gastier-Foster JM; Nationwide Children's Hospital, Columbus, OH, USA.; Departments of Pathology and Pediatrics, The Ohio State University, Columbus, OH, USA., Yarchoan R; Office of HIV and AIDS Malignancy, National Cancer Institute, National Institues of Health, Bethesda, MD, USA.; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Casper C; Infectious Disease Research Institute, Seattle, WA, USA., Mills GB; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA., Rader JS; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA., Ojesina AI; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.; HudsonAlpha Institute for Biotechnology, Huntsville, AL, USA., Gerhard DS; Office of Cancer Genomics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Mungall AJ; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada., Marra MA; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada. mmarra@bcgsc.ca.; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada. mmarra@bcgsc.ca.

Publikováno v: Nature genetics [Nat Genet] 2020 Aug; Vol. 52 (8), pp. 800-810. Date of Electronic Publication: 2020 Aug 03.

ERG oncoprotein inhibits ANXA2 expression and function in prostate cancer.

Autor: Griner NB; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Rockville, Maryland., Young D; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Rockville, Maryland., Chaudhary P; Department of Molecular and Medical Genetics, Texas Center for Health Disparities and the Institute for Cancer Research, University of North Texas Health Science Center, Fort Worth, Texas., Mohamed AA; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Rockville, Maryland., Huang W; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Rockville, Maryland., Chen Y; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Rockville, Maryland., Sreenath T; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Rockville, Maryland., Dobi A; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Rockville, Maryland., Petrovics G; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Rockville, Maryland., Vishwanatha JK; Department of Molecular and Medical Genetics, Texas Center for Health Disparities and the Institute for Cancer Research, University of North Texas Health Science Center, Fort Worth, Texas., Sesterhenn IA; Joint Pathology Center, Silver Spring, Maryland., Srivastava S; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Rockville, Maryland., Tan SH; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Rockville, Maryland. Stan@cpdr.org.

Publikováno v: Molecular cancer research : MCR [Mol Cancer Res] 2015 Feb; Vol. 13 (2), pp. 368-79. Date of Electronic Publication: 2014 Oct 24.

Mitochondrial dysfunction impairs tumor suppressor p53 expression/function.

Autor: Compton S; Pioneer Valley Life Sciences Institute, Springfield, Massachusetts 01107, USA., Kim C, Griner NB, Potluri P, Scheffler IE, Sen S, Jerry DJ, Schneider S, Yadava N

Publikováno v: The Journal of biological chemistry [J Biol Chem] 2011 Jun 10; Vol. 286 (23), pp. 20297-312. Date of Electronic Publication: 2011 Apr 18.